Comments on Nomenclature of COVID-19 |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.9, No. 6)Publication Date: 2020-07-31
Authors : Li Liu; Yumin Huang-Link;
Page : 488-489
Keywords : Scientists; Medical; Doctors; Syndrome; Coronavirus;
Abstract
Scientists and medical doctors have been contributing largely to identify novel coronavirus 2 as the cause of the severe acute respiratory syndrome (SARS-COV-2) which emerged in large numbers of infected people in Wuhan City since Dec. 2019 [1-3]. Scientists quickly sequenced SARS-COV-2 and shared their knowledge with the world [3,4]. Searching for vaccine and specific therapy is the ongoing global public health concern to prevent future spreading [5]. The new research, clinical and epidemiological data on SARS-COV-2 are continuing to explode. We need to make consensus on nomenclature in SARS-COV-2 studies correctly and precisely.
Other Latest Articles
- Using Health Coaching to Improve Glycemic Control in African-American Diabetics: An Integrative Review |Biomedgrid
- Deciphering Interactive Associations of Antiviral and Electron-Shuttling Characteristics of Flavonoid Compounds for Antiviral Drug Development |Biomedgrid
- ED Acuity in Patients with Respiratory Complaint During the COVID-19 Pandemic: A Single-center Experience |Biomedgrid
- Performance of Commercially Antibody-based assays for Covid-19 Detection |Biomedgrid
- Ameliorative Effects of Dried and Germinated Fenugreek Seeds on Kidney Failure Induced by Gentamicin in Male Mice |Biomedgrid
Last modified: 2023-06-21 21:55:50